Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group. (Q30985931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

acute myeloid leukemia

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Camillo Almici

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Giuseppe Leone

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

L Pagano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Pulsoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Mele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Cerri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

G Visani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Melillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Candoni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Clavio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Nosari

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M C Petti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Martino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Mele

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Levis

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Allione

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Equitani

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Mandelli

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gruppo Italiano Malattie Ematologiche dell'Adults

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

203-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300325%20AND%20SRC:MED&resulttype=core&format=json

Two different classes of therapy-related and de-novo acute myeloid leukemia?

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Melphalan may be a more potent leukemogen than cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Increase therapy-related leukemia secondary to breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Leukemia in patients with breast cancer following adjuvant chemotherapy and/or postoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Second cancers and other late side effects of cancer treatment. A review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

Association of cancer of the breast and acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008318816244

7 January 2021